Back to search
Refractory Cold Agglutinin Disease
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Refractory Cold Agglutinin Disease trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Refractory Cold Agglutinin Disease trials you may qualify forTo evaluate the efficacy and safety of ipecopam in the treatment of refractory/relapsed AIHA.
This multicenter, phase II, open label study will enroll patients with chronic cold agglutinin disorder. A single course of Bortezomib will be given at the dose…